PDCD1 and osteosarcoma: Besides, some osteosarcomas have an elevated programmed cell death protein-1 ligand (PD-L1) expression, with a high level of genomic instability, indicating prospective sensitivity to programmed cell death protein-1 (PD-1)/PD-L1 cascade suppressors (Shen et al., 2014).